April 8, 2014

NanoMedSyn signs a 3-year cooperative grant in the program «Program Nanotechnologies and Nanosystems (P2N)”, with Agence Nationale de la Recherche: “BIOSIPHARM: Biosafety of mesoporous silica nanoparticles according to their surface coverage and establishing standards for evaluation”. Partners: Institute Charles Gerhardt, CNRS UMR 5253, directed by Pr Jean-Marie Devoisselle, Montpellier 34, and IBEB/SBTN, directed of Dr Odette Part, Centre Energie Atomique (CEA), Marcoule 30.